prior to discussing detailed aspects of the invention , a general overview will be provided . the invention provides an improvement over prior art sulfur - based nicotine withdrawal products which block nicotine from binding with cell receptor sites . the prior art has focused its attention on the use of a variety of sulfur based compounds to treat nicotine addiction . however , it has not placed significant emphasis on the side effects associated with nicotine withdrawal . in particular , a frequent side effect associated with smoking cessation is a marked increase in appetite . the increase in appetite often results in an individual having the health benefits associated with cessation of smoking offset by the health hazards produced by excessive weight gain . these are increased insulin levels that can lead to insulin resistance , increased blood pressure , and unfavorable changes in lipid profiles . the present invention overcomes these problems by providing a single therapeutic compound which simultaneously reduces nicotine craving to assist an individual to cease smoking , alters the perceived taste of tobacco smoke to deter relapse , and simultaneously suppresses the individual &# 39 ; s appetite to avoid unnecessary and undesirable side effects , such as weight gain , associated with the cessation of smoking . the compound provided by the present invention provides an unexpected effect . namely , the ingredients of the compound work in conjunction with the suppression of nicotine cravings to further discourage smokers by altering the perceived taste of tobacco smoke . in particular , the compound alters the perceived taste of tobacco smoke such that it has an unpleasant taste that discourages relapse . the invention takes advantage of known sulfur based compounds which interfere with the binding of nicotine with cell receptor sites . these compounds , and their method of use , are discussed in detail in u . s . pat . nos . 4 , 416 , 869 and 4 , 596 , 706 , which are incorporated by reference herein in their entirety . applicant &# 39 ; s invention improves over these prior art inventions by adding compounds which are specifically designed to reduce the increased appetite which is caused by nicotine withdrawal . further , the compounds selected to reduce appetite also enhance the body &# 39 ; s ability to suppress nicotine cravings . as a result , an individual seeking to cease smoking will not have the additional problems generated by the common side effect of nicotine withdrawal , namely , increased appetite and weight gain . applicant &# 39 ; s invention provides a treatment regimen that works synergistically to overcome nicotine addiction while reducing the side effect of increased appetite that often occurs during nicotine withdrawal . having discussed the features and advantages of the invention in general , we turn now to a more detailed discussion of the figures . as discussed above , the u . s . pat . nos . 4 , 416 , 869 and 4 , 596 , 706 teach a variety of sulfur based compounds which are useful in the treatment of nicotine addiction . in particular , these patents teach the use of bivalent negative sulfur compounds which are useful for reducing nicotine craving in individual &# 39 ; s seeking to cease smoking tobacco products . however , these products do not effectively address side effects related to the cessation of smoking , most notably : unwanted weight gain due to increased appetite . an advantage of applicant &# 39 ; s invention is that it allows an individual to cease smoking without this undesirable side effect . applicant &# 39 ; s invention provides a new compound which incorporates known compounds in the prior art ( related to suppression of nicotine addiction ) with a second compound that combined with the first compound to simultaneously suppress the unwanted increase in appetite which occurs during nicotine withdrawal . applicant &# 39 ; s invention uses derivatives of the amino acid tryptophan to reduce appetite so that an individual can cease smoking tobacco products without the added stress and health hazards related to excessive weight gain . the combination of these compounds produces an unexpected effect , namely , the perceived taste of tobacco smoke becomes unpleasant . as a result of this change in perceived taste , it becomes easier for a smoker to overcome a tobacco addiction . in the preferred embodiment , both the compounds related to nicotine addiction , and the amino acids used for appetite suppression are combined for ingestion by the individual . those skilled in the art will recognize that these compounds can be administered via a variety of methods , such as pills / capsule ingestion , liquid ingestion , intramuscular injection , intravenous injection , nasal spray , or via inhaler . when used as a liquid , the compound can be administered in combination with any suitable solution , liquid carrier , liquid medium , etc . the only requirement is that liquid selected is suitable for use with the components of the compound . however , while a variety of administration methods can be used ( e . g ., injection , transdermal patches , creams , gels , ointments , lozenges , gums , etc . ), the preferred embodiment envisions the simple and convenient process of administering the compound via a pill or capsule . in the preferred embodiment , the tryptophan derivative used by the applicant is 5 - hydroxytryptophan (“ 5 - htp ”), which is a nutrient . it is derived from the amino acid l - tryptophan . l - tryptophan plays a vital role in our health . tryptophan an essential amino acid for building proteins and enzymes , and serves as the precursor for serotonin , and the hydrogen carriers nadh and nadph . 5 - htp functions as a precursor to serotonin ( 5 - ht , 5 - hydroxytryptamine ). serotonin , a neurotransmitter , plays an important role in regulation of mood , appetite , body temperature , and the secretion of various hormones . while serotonin does not readily cross the blood brain barrier , serotonin precursors such as l - tryptophan and 5 - htp can . supplementation with these precursors increases levels of serotonin . in addition , 5 - htp is more efficient than l - tryptophan because it bypasses the rate - limiting step of serotonin synthesis ( tryptophan hydroxylase ). tryptophan has a variety of side effects when ingested by humans . it can be used as a mood - enhancer , and it can help individuals sleep . in fact , it has been widely used to treat insomnia and depression . it can increase pain tolerance , and it can also reduce appetite . an advantage of 5 - htp over some other appetite suppressants is that it has small molecule size . the 5 - htp accesses the brain from the bloodstream , and once in the brain , it can be converted into serotonin . it is the serotonin , created from the 5 - htp , acting on the different serotonin receptor sites , which ultimately acts as an appetite suppressant , and helps to reduce cravings for nicotine . a further advantage of 5 - htp over other potential appetite suppressants is that it is a naturally occurring compound which is produced in the body from tryptophan which is found in high - protein foods such as beef , chicken , fish , and / or dairy products . a normal variety of food products will include many items that are rich in tryptophan . in the preferred embodiment , the dosage level of 5 - htp ranges from 50 mg per day up to 900 mg per day . 700 to 900 mg of 5 - htp would normally be considered a high dose . of course , those skilled in the art will recognize that there are many factors that influence the appropriate dosage level for an individual . for example , the size , weight and tolerance of individuals can vary widely . therefore , an appropriate dosage for one individual may not be safe for another . a large individual may have the ability to use dosage levels well in excess of 900 mg . some individuals may also have high tolerance levels for particular compounds which will result in the ability to use high dosage levels . of course the opposite will be true for individuals who are small or particularly sensitive to a given compound . in addition , other factors related to an individual may create higher or lower levels of appetite which would necessitate the change in dosage levels . as a result , unique factors related to each individual should be taken into account when determining the proper levels of each of the components of the compound . in the preferred embodiment , the compound would be taken at least twice a day , to maintain stable levels of nicotine suppressant . in addition , it has been found that the appetite suppressant is more effective if taken before or after meals , because it is absorbed by the body more rapidly if taken on an empty stomach . as a result , an individual would preferably take the compound approximately an hour before meals , or approximately 2 hours after meals . typically , an individual would take a dose at least twice a day . this would maintain relatively stable levels of nicotine suppressant throughout the day , and will also suppress hunger at the appropriate times . because 5 - htp is a precursor used by the body to produce serotonin which suppresses appetite , its use in combination with the aforementioned nicotine suppressant allows an individual to improve the chances of successfully overcoming a tobacco habit . this is because the individual will not have negative side effects such as increased weight gain , which may in fact frustrate the individual to the point where they resume smoking . due to that , the individual is more likely to succeed when attempting to quit smoking . of course , avoiding unnecessary weight gain provides many advantages for the overall health of the individual . in addition , because serotonin also inhibits cravings for nicotine , it will synergistically enhance the effect of the sulfur based compounds that are directed specifically at reducing nicotine cravings . magnesium and 5 - htp work synergistically to decrease anxiety . magnesium prolongs the effects of 5 - htp . an appropriate dose of magnesium is preferably 50 - 300 mg per day . in addition to the use of 5 - htp to suppress appetite , other additives may be included in the compound to enhance weight control . for example , there are a number of nutritional supplements which enhance the body &# 39 ; s ability to metabolize fat , such as vitamin b12 , inositol , methionine , and choline . additives such as this complement the appetite suppression by enhancing the body &# 39 ; s ability to metabolize fat . therefore , these additives would also help reduce the risk of weight gain during smoking cessation . inositol , in all of its forms , may be helpful in multiple ways . higher doses may help increase gaba and reduce anxiety as does magnesium and 5 - htp . inositol augments the effects of neurotransmitter release . while medical literature suggests that individuals may safely ingest 1 - 18 grams per day , the preferred embodiment envisions a dosage level of approximately 100 mg - 2 gram / day . another effective additive is gaba at 100 - 2250 mg per day to decrease anxiety . gaba may be added directly , or gaba agonists , such as taurine 500 - 3000 mg per day ), indirect gaba agonist such as l - theanine ( 100 - 800 mg per day ). magnolia officianalis ( used in seditol ™) works on the gaba sites to reduce anxiety and on the adenosine a1 sites to lower anxiety and stress , magnesium malate ( 200 - 400 mg per day ), vitamin b - 6 ( as pyridoxal hydrochloride and / or pyridoxal 5 - phosphate , 25 - 50 mg per day ), vitamin b6 is a cofactor in the synthesis of gaba from the enzyme glutamate acid decarboxylase ( gad ), n - acetyl cysteine ( nac , 100 - 2000 mg per day ) is a novel glutamate antagonist . it down - regulates glutamate activity by its involvement with the cysteine - glutamate transporter . there is intracellular entry of cysteine in exchange for transport of glutamate . it inhibits excitatory neurotransmission by activation of the xc - transporter , promoting metabotropic receptors an inhibiting glutamate . also , glycine , niacinamide , valerian root , kava kava , and green tea may be used . green tea extract ( camilla sinensis ) 60 % catechins , 40 % egcg can be used at 300 - 600 mg per day . taurine activates gaba a receptors in the hippocampus and stabilizes membranes . taurine enhances brain gaba levels by inhibiting gaba transaminase and stimulating gad . anxiolytic effect has been observed in animals . gaba is an inhibitory neurotransmitter that functions as : calming , stabilizing , antianxiety . gaba is the primary inhibitory neurotransmitter in the brain . gaba deficiency manifests as : anxiety , tremor , insomnia , tension , cardiac dysrhythmia , manic depression , ocd , adjustment disorders , phobias , and restlessness . another effective additive is dopamine , which is a neurotransmitter . l - tyrosine 100 - 500 mg a day as well as n - acetyl tyrosine 100 - 500 mg a day and l or dl - phenylalanine 100 - 500 mg a day will increase dopamine along with the b - vitamins . the addition of the neurotransmitter precursor of dopamine may also help decrease cravings for certain carbohydrates like sweets , but also salt and fat . the l - phenylalanine form may work best . other optional additives can also be usefully combined with the compound . for example , alpha - lipoic acid may help reduce cravings for sweets by regulating blood sugar . likewise , chromium picolinate , the chromium product , chromium polynicotinate ™, biotin , and butyrate can be helpful in regulating blood sugar metabolism and may be included in the compound . chromium and biotin synergistically improved glucose tolerance . biotin 5 - 15 mg enhances the effects of enzymes involved in glucose metabolism . chromium polynicotinate may increase insulin receptor sensitivity and enhanced glucose uptake . alpha lipoic acid stimulates the uptake of glucose via stimulation of glut - 4 protein ( primary glucose transporter in muscle , cardiac and fat cells ). alpha lipoic acid decreases appetite because it decreases amp kinase in the brain and increases amp kinase in peripheral tissues thus improving blood sugar regulation . alpha lipoic acid turns on pgc alpha that turns on gaba receptors . butyrate improves insulin sensitivity . in addition to these nutritional supplements , vitamin b6 increases the efficacy of the conversion of 5 - htp to serotonin . therefore , their inclusion in the compound may result in greater serotonin levels . in the preferred embodiment , at least twice a day , the following doses should be taken : 1 . 50 - 500 mg 5 - htp 2 . 60 - 480 mg thioglycerol 3 . 25 mg - 2 gram choline in any of its forms ( choline as choline citrate or phosphatidylcholine ) 4 . 25 - 100 mg pantothenic acid ( as d - calcium pantothenate ) 5 . 200 mg - 2 gram inositol 6 . 25 - 100 mg l - methionine 7 . 50 - 500 mg alpha lipoic acid 8 . 25 - 50 mg vitamin b - 6 ( as pyridoxine hcl and / or pyridoxal 5 - phosphate , note : vitamin b - 6 ( helps with conversion of 5 - htp to serotonin ) 9 . 25 mg - 2 gram vitamin c 10 . 200 mcg - 5 mg folic acid and / or folinic acid and / or l - methylfolate , or any other forms of folic acid 11 . 50 mcg - 1 mg vitamin b12 ( as methylcobalamin or cyanocobalamin ) 12 . 25 - 400 mg magnesium citrate and / or magnesium glycinate and / or magnesium malate 13 . 100 - 500 mg l - tyrosine 14 . 100 - 500 mg n - acetyl tyrosine 15 . 100 - 500 mg l or dl - phenylalanine 16 . 50 - 800 mg l - theanine ( for gaba and dopamine modulation and to lower norepinepherine ) 17 . 500 mg - 10 gram butyrate in the forms of sodium butyrate and / or sodium potassium butyrate and / or calcium magnesium butyrate 18 . 365 - 720 mg in seditol ™ ( a proprietary blend of patented natural plant extracts from magnolia officinalis and ziziphus spinosa ) 19 . 100 - 800 mg gaba or gaba agonists ( such as taurine ( 50 - 3000 mg per day ), indirect gaba agonists such as l - theanine ( 100 - 400 mg per day ), magnolia officianalis ( used in seditol ™), magnesium malate , vitamin b - 6 ( as pyridoxal hydrochloride and / or pyridoxal 5 - phosphate , 25 - 50 mg per day ), n - acetyl cysteine ( nac , 50 - 2000 mg per day ). also , glycine , niacinamide , valerian root , kava kava , and green tea with epigallocatechin gallate ( egcg ) binds to gaba receptors and reduces plasma cortisol levels in animals after social separation stress may be used ) 20 . 10 - 40 mg vinpocetine l - theanine does not directly increase gaba . it is a gaba modulator that dampens glutamate . it acts as a glutamate antagonist and also acts to modulate dopamine . it also lowers norepinepherine . as a glutamate antagonist that modulates gaba and dopamine , l - theanine helps you stay calm . magnolia officinalis ( found in seditol ™) works on the gaba a site to reduce anxiety , and also works on the adenosine al sites that can lower anxiety and stress . butyrate 500 mg - 10 grams has been found to improve insulin sensitivity . it is preferably used in the form of sodium butyrate , sodium potassium butyrate , or calcium / magnesium butyrate . other forms may also be used . those skilled in the art will recognize that while the aforesaid formula is preferred , changes can be made to the formula without losing its overall effectiveness . two components of the compound are the most important . the first component is 5 - htp which is used to suppress appetite . in the preferred embodiment , this is administered in an approximate dosage of 200 mg . the second compound is thioglycerol , which is a sulfur based compound that is used to block nicotine receptor cells . by blocking the receptor cells , nicotine cravings are reduced . the thioglycerol is typically administered in an approximate dosage of 120 mg . the combination of these two components provides a compound that reduces nicotine cravings while simultaneously reducing appetite . in addition , the compound used by the invention has been found to have an unexpected effect . in particular , after taking the compound for approximately three days , users have been found to experience a change in the perceived taste of cigarette smoke , wherein the smoke takes on an unpleasant taste . the unpleasant taste bolsters the user during the withdrawal process facilitating smoking cassation , and they won &# 39 ; t enjoy smoking if they relapse . in addition to the two primary components , namely sulfur compounds used to block nicotine receptor cells , and the 5 - htp , which is used to increase serotonin levels , a variety of optional additional components can be used to enhance performance of the product . for example , weight suppression can be further enhanced through the use of inositol , vitamin b12 ( as methylcobalamin ), l - methionine , and choline . they can be used with one another to increase the body &# 39 ; s ability to metabolize fat , and thereby helping the body to avoid weight gain . b vitamins , such as vitamin b - 6 ( as pyridoxine hcl , or pyridoxal 5 - phosphate , p - 5 - p ), pantothenic acid ( as d - calcium pantothenate ), and folic acid are precursors to , or co - factors for neurotransmitters , which will decrease cravings for certain carbohydrates . folic acid is also a natural serotonin agonist . it is a cofactor in serotonin synthesis . alpha lipoic acid is helpful in stabilizing blood sugar levels . the magnesium compounds may work synergistically with 5 - htp to reduce anxiety . those skilled in the art will recognize that as is the case with any pharmaceutical or neutraceutical , appropriate dosages will vary based on several factors . a person &# 39 ; s weight , age , physical condition , etc ., will all influence what the proper dosage for a particular individual should be . as a result , while the foregoing dosages are envisioned as an appropriate starting point , changes can be made to suit a particular individual &# 39 ; s unique biochemical diversity . currently , there are more than 1 billion smokers on earth , and more than 400 , 000 americans die annually of tobacco - related illnesses each year . more than 8 million americans suffer from at least one serious illness caused by smoking ; and almost 90 percent of all smokers begin at or before age 18 in the united states . the current invention seeks to reduce these numbers by providing a multimodal synergistic compound that reduces nicotine craving , that makes tobacco smoke taste unpleasant , and that helps with side effects of smoking cessation such as weight gain . while the invention has been described with respect to a preferred embodiment thereof , it will be understood by those skilled in the art that various changes in detail may be made therein without departing from the spirit , scope , and teaching of the invention . for example , the compound used to suppress appetite can vary so long as it is suitable for its purpose , the amount of the appetite suppressant can vary based on an individual &# 39 ; s physical requirements . the type of administration can vary from pill / capsule form to liquid form , injection , transdermal patch , creams , gels , ointments , gums , lozenges , etc . in addition , the dose and frequency of administration can vary based on the number of daily meals , severity of withdrawal systems , the weight and condition of the individual , etc . accordingly , the invention herein disclosed is to be limited only as specified in the following claims . i claim :